Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Neoplasms | 68 | 2024 | 5686 | 9.700 |
Why?
|
Carcinoma, Squamous Cell | 39 | 2024 | 4034 | 7.650 |
Why?
|
Carcinoma, Basal Cell | 19 | 2023 | 545 | 7.020 |
Why?
|
Mohs Surgery | 15 | 2023 | 197 | 2.720 |
Why?
|
Neoplasm Staging | 24 | 2023 | 11031 | 1.350 |
Why?
|
Acitretin | 2 | 2023 | 14 | 1.020 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2023 | 25 | 0.870 |
Why?
|
Neoplasm Recurrence, Local | 16 | 2023 | 9239 | 0.870 |
Why?
|
Keratosis, Actinic | 2 | 2020 | 74 | 0.860 |
Why?
|
Skin | 8 | 2023 | 4364 | 0.860 |
Why?
|
Sweat Glands | 1 | 2022 | 31 | 0.840 |
Why?
|
Eyelid Neoplasms | 1 | 2023 | 94 | 0.830 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2023 | 300 | 0.830 |
Why?
|
Keratolytic Agents | 1 | 2021 | 31 | 0.780 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2021 | 1770 | 0.770 |
Why?
|
Photochemotherapy | 3 | 2021 | 807 | 0.710 |
Why?
|
Retrospective Studies | 36 | 2023 | 77449 | 0.680 |
Why?
|
Psoriasis | 2 | 2023 | 898 | 0.660 |
Why?
|
Mouth Neoplasms | 1 | 2023 | 601 | 0.630 |
Why?
|
Neoplasm Invasiveness | 8 | 2023 | 3616 | 0.590 |
Why?
|
Niacinamide | 3 | 2023 | 417 | 0.560 |
Why?
|
Neoplasms, Second Primary | 2 | 2020 | 1061 | 0.520 |
Why?
|
Lymphatic Vessels | 1 | 2019 | 353 | 0.520 |
Why?
|
Medicare Part D | 1 | 2020 | 328 | 0.520 |
Why?
|
Humans | 85 | 2024 | 744343 | 0.510 |
Why?
|
Insurance Claim Review | 1 | 2019 | 720 | 0.500 |
Why?
|
Salvage Therapy | 1 | 2021 | 1275 | 0.490 |
Why?
|
Clinical Protocols | 1 | 2020 | 1462 | 0.470 |
Why?
|
Blood Vessels | 1 | 2019 | 1125 | 0.460 |
Why?
|
Aftercare | 1 | 2019 | 866 | 0.450 |
Why?
|
Prognosis | 14 | 2023 | 29063 | 0.450 |
Why?
|
Organ Transplantation | 1 | 2023 | 1139 | 0.450 |
Why?
|
Prescription Drugs | 1 | 2020 | 595 | 0.430 |
Why?
|
Dermatology | 3 | 2020 | 872 | 0.430 |
Why?
|
Health Care Costs | 3 | 2023 | 3209 | 0.420 |
Why?
|
Antineoplastic Agents | 6 | 2023 | 13695 | 0.420 |
Why?
|
Health Expenditures | 4 | 2021 | 2348 | 0.410 |
Why?
|
Head and Neck Neoplasms | 3 | 2019 | 2734 | 0.400 |
Why?
|
Melanoma | 5 | 2023 | 5510 | 0.400 |
Why?
|
Immunotherapy | 5 | 2022 | 4445 | 0.400 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2727 | 0.390 |
Why?
|
Sarcoma | 1 | 2022 | 1897 | 0.380 |
Why?
|
Carcinoma | 1 | 2022 | 2375 | 0.370 |
Why?
|
Chemoprevention | 2 | 2023 | 319 | 0.350 |
Why?
|
Cohort Studies | 15 | 2023 | 40561 | 0.350 |
Why?
|
Nervous System Neoplasms | 2 | 2020 | 91 | 0.340 |
Why?
|
Kidney Transplantation | 2 | 2024 | 4251 | 0.340 |
Why?
|
Injections, Intralesional | 2 | 2020 | 276 | 0.340 |
Why?
|
Combined Modality Therapy | 4 | 2023 | 8642 | 0.330 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2425 | 0.330 |
Why?
|
Keratinocytes | 3 | 2021 | 798 | 0.330 |
Why?
|
Early Detection of Cancer | 2 | 2019 | 3086 | 0.320 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3712 | 0.310 |
Why?
|
Medicare | 4 | 2023 | 6566 | 0.310 |
Why?
|
Hedgehog Proteins | 4 | 2023 | 783 | 0.260 |
Why?
|
Lymphatic Metastasis | 3 | 2022 | 2924 | 0.250 |
Why?
|
Patient Selection | 1 | 2016 | 4215 | 0.240 |
Why?
|
Fellowships and Scholarships | 2 | 2023 | 1076 | 0.230 |
Why?
|
Mass Screening | 1 | 2019 | 5255 | 0.230 |
Why?
|
Female | 31 | 2023 | 380194 | 0.230 |
Why?
|
Philadelphia | 1 | 2023 | 266 | 0.220 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5319 | 0.220 |
Why?
|
Fluorouracil | 2 | 2020 | 1619 | 0.220 |
Why?
|
United States | 12 | 2023 | 69872 | 0.220 |
Why?
|
Aged | 20 | 2023 | 163280 | 0.210 |
Why?
|
Hospitals, Private | 2 | 2010 | 63 | 0.210 |
Why?
|
Male | 29 | 2023 | 350118 | 0.200 |
Why?
|
Skin Pigmentation | 2 | 2020 | 282 | 0.200 |
Why?
|
Hospitals, Public | 2 | 2010 | 207 | 0.190 |
Why?
|
Arthritis, Psoriatic | 1 | 2013 | 215 | 0.190 |
Why?
|
Hospitals | 3 | 2023 | 3952 | 0.180 |
Why?
|
Pyloric Stenosis | 1 | 2010 | 29 | 0.180 |
Why?
|
Dermatologic Agents | 1 | 2013 | 278 | 0.180 |
Why?
|
Neoplasm Metastasis | 2 | 2021 | 4851 | 0.180 |
Why?
|
Health Services Needs and Demand | 2 | 2015 | 1411 | 0.170 |
Why?
|
Diagnostic Imaging | 3 | 2023 | 3507 | 0.170 |
Why?
|
Scalp | 1 | 2012 | 380 | 0.170 |
Why?
|
Risk Factors | 7 | 2023 | 72290 | 0.170 |
Why?
|
Algorithms | 1 | 2019 | 13881 | 0.170 |
Why?
|
Calcitriol | 1 | 2020 | 298 | 0.160 |
Why?
|
September 11 Terrorist Attacks | 1 | 2009 | 113 | 0.160 |
Why?
|
Ultraviolet Rays | 2 | 2020 | 1060 | 0.160 |
Why?
|
Curriculum | 2 | 2023 | 3605 | 0.160 |
Why?
|
Organizational Innovation | 1 | 2021 | 559 | 0.160 |
Why?
|
Administration, Cutaneous | 1 | 2020 | 711 | 0.160 |
Why?
|
Cisplatin | 1 | 2023 | 1662 | 0.150 |
Why?
|
Hospitals, University | 1 | 2009 | 571 | 0.140 |
Why?
|
Aged, 80 and over | 7 | 2020 | 57776 | 0.140 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3610 | 0.140 |
Why?
|
Skin Diseases | 2 | 2015 | 1065 | 0.140 |
Why?
|
Drug Synergism | 1 | 2020 | 1792 | 0.130 |
Why?
|
Educational Status | 1 | 2023 | 2540 | 0.130 |
Why?
|
Treatment Outcome | 8 | 2020 | 63114 | 0.130 |
Why?
|
Cryosurgery | 1 | 2020 | 453 | 0.130 |
Why?
|
Aminoquinolines | 1 | 2015 | 109 | 0.130 |
Why?
|
Neoadjuvant Therapy | 2 | 2023 | 2728 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1681 | 0.130 |
Why?
|
Drugs, Generic | 1 | 2020 | 421 | 0.130 |
Why?
|
Radiotherapy | 1 | 2022 | 1533 | 0.120 |
Why?
|
Middle Aged | 13 | 2023 | 213383 | 0.120 |
Why?
|
Risk Assessment | 4 | 2023 | 23338 | 0.120 |
Why?
|
Trauma Centers | 1 | 2009 | 890 | 0.120 |
Why?
|
Physician's Role | 1 | 2021 | 943 | 0.120 |
Why?
|
Lymph Nodes | 2 | 2023 | 3474 | 0.120 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2291 | 0.120 |
Why?
|
Child Health Services | 1 | 2009 | 667 | 0.110 |
Why?
|
Disaster Planning | 1 | 2009 | 549 | 0.110 |
Why?
|
Pilot Projects | 2 | 2022 | 8324 | 0.110 |
Why?
|
Follow-Up Studies | 5 | 2023 | 39050 | 0.110 |
Why?
|
Appendicitis | 1 | 2009 | 645 | 0.110 |
Why?
|
Influenza Vaccines | 1 | 2019 | 738 | 0.100 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25043 | 0.100 |
Why?
|
Drug Costs | 1 | 2020 | 1105 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1782 | 0.100 |
Why?
|
Clinical Competence | 2 | 2019 | 4687 | 0.100 |
Why?
|
Recurrence | 1 | 2022 | 8340 | 0.090 |
Why?
|
Edema | 1 | 1994 | 789 | 0.090 |
Why?
|
Surgical Procedures, Operative | 1 | 2022 | 1876 | 0.090 |
Why?
|
Eosinophilia | 1 | 1994 | 541 | 0.090 |
Why?
|
Patient Compliance | 1 | 2010 | 2684 | 0.090 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2759 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2212 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12354 | 0.080 |
Why?
|
Incidence | 4 | 2020 | 20947 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2265 | 0.080 |
Why?
|
Internship and Residency | 2 | 2021 | 5788 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2459 | 0.080 |
Why?
|
Survival Rate | 2 | 2019 | 12788 | 0.080 |
Why?
|
Emergency Medical Services | 1 | 2009 | 1917 | 0.080 |
Why?
|
New York City | 2 | 2010 | 710 | 0.080 |
Why?
|
Veterans | 1 | 2021 | 2519 | 0.070 |
Why?
|
Survival Analysis | 4 | 2023 | 10252 | 0.070 |
Why?
|
Reoperation | 1 | 2016 | 4201 | 0.070 |
Why?
|
Boston | 1 | 2019 | 9313 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11524 | 0.070 |
Why?
|
Registries | 2 | 2019 | 8089 | 0.070 |
Why?
|
Adult | 8 | 2023 | 214055 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20129 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14722 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9959 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15076 | 0.060 |
Why?
|
Pneumonia, Viral | 1 | 2021 | 3240 | 0.060 |
Why?
|
Radioimmunotherapy | 1 | 2012 | 91 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2009 | 5137 | 0.050 |
Why?
|
Antigens, Nuclear | 1 | 2012 | 192 | 0.050 |
Why?
|
Pamphlets | 1 | 2021 | 75 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 35421 | 0.050 |
Why?
|
Amides | 1 | 2023 | 459 | 0.050 |
Why?
|
Models, Econometric | 1 | 2021 | 218 | 0.050 |
Why?
|
Squalene | 1 | 2019 | 32 | 0.050 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 154 | 0.040 |
Why?
|
Joint Diseases | 1 | 2013 | 480 | 0.040 |
Why?
|
Anilides | 1 | 2022 | 408 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7279 | 0.040 |
Why?
|
Vitamin B Complex | 1 | 2021 | 288 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2023 | 709 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.040 |
Why?
|
Germany | 1 | 2019 | 862 | 0.040 |
Why?
|
Remission Induction | 1 | 2022 | 2386 | 0.040 |
Why?
|
Ligands | 1 | 2023 | 3282 | 0.040 |
Why?
|
Australia | 1 | 2019 | 1170 | 0.030 |
Why?
|
Appendectomy | 1 | 2009 | 401 | 0.030 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2019 | 459 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6895 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2022 | 1405 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2018 | 402 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13284 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1855 | 0.030 |
Why?
|
Lichenoid Eruptions | 1 | 1994 | 14 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2019 | 1000 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1683 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2019 | 1200 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2012 | 1988 | 0.030 |
Why?
|
Blister | 1 | 1994 | 86 | 0.030 |
Why?
|
Video Recording | 1 | 2019 | 949 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1493 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10397 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1915 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1607 | 0.030 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 1994 | 85 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2886 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1372 | 0.030 |
Why?
|
Pemphigoid, Bullous | 1 | 1994 | 109 | 0.030 |
Why?
|
Exocytosis | 1 | 1994 | 353 | 0.030 |
Why?
|
Radiosurgery | 1 | 2012 | 1329 | 0.030 |
Why?
|
Dermatitis | 1 | 1994 | 197 | 0.030 |
Why?
|
Complement C3 | 1 | 1994 | 461 | 0.030 |
Why?
|
Brachytherapy | 1 | 2019 | 1248 | 0.030 |
Why?
|
Social Class | 1 | 2010 | 1999 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2021 | 2278 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18370 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21683 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2951 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1994 | 2505 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2531 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3703 | 0.020 |
Why?
|
Laryngeal Cartilages | 1 | 1989 | 22 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2015 | 806 | 0.020 |
Why?
|
Cricoid Cartilage | 1 | 1989 | 72 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2019 | 3023 | 0.020 |
Why?
|
Influenza, Human | 1 | 2019 | 1479 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5391 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 5987 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3229 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3278 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3586 | 0.020 |
Why?
|
Child | 3 | 2010 | 77709 | 0.020 |
Why?
|
Laparoscopy | 1 | 2009 | 2151 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4665 | 0.020 |
Why?
|
Length of Stay | 1 | 2010 | 6309 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7913 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2010 | 7659 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8663 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2009 | 7785 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 9274 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3158 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1989 | 664 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4371 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 1994 | 4560 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21827 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9856 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12804 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2012 | 8863 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13408 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 25625 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1994 | 12959 | 0.010 |
Why?
|
Adolescent | 2 | 2009 | 85781 | 0.010 |
Why?
|
Infant | 1 | 2010 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2009 | 41006 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13102 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 53288 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81183 | 0.010 |
Why?
|
Succinylcholine | 1 | 1989 | 67 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168757 | 0.000 |
Why?
|
Intubation, Intratracheal | 1 | 1989 | 1364 | 0.000 |
Why?
|
Heart Arrest | 1 | 1989 | 1470 | 0.000 |
Why?
|
Respiration, Artificial | 1 | 1989 | 2569 | 0.000 |
Why?
|
Concepts
(244)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_